Close monitoring via weekly complete blood counts (CBCs) for the first 2 months is essential to mitigate risks, according to Zeidan. Supportive care such as platelet transfusions or growth factors may ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to ...

New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie's growing ADC ...

AbbVie (ABBV) announced it will unveil new data from its robust antibody-drug conjugate platform at the 2025 European Society ...

Chemotherapy fights lung cancer by targeting fast-growing cells. This treatment can cause fatigue, nausea, hair loss, and ...

The U.S. health regulator has deferred a decision on Spectrum Pharmaceuticals' drug candidate to treat chemotherapy induced loss of white blood cells in cancer patients due to COVID-19 related travel ...

T-cell therapy has revolutionised the treatment of B-cell malignancies, offering durable responses for patients with relapsed ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq® ...

A technique to estimate the health of specialized nerve cells may help predict patient response to Zolgensma gene therapy, a ...

Researchers sought to determine whether adding nivolumab to AVD would be an effective treatment for older patients with classic HL.

is a clinical-stage biopharmaceutical company, which engages in developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform ...

The FDA rejected brexpiprazole (Rexulti) in combination with sertraline for post-traumatic stress disorder (PTSD), said makers Otsuka Pharmaceutical and H. Lundbeck.